Clinical Transplant-Related Long-term Outcomes of Alternative Donor Allogeneic Transplantation (CTRLALT-D)

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Non-Hodgkin Lymphoma | Sickle Cell Disease | Acute Myeloid Leukemia | Myelodysplatic syndromes | Hodgkin's Lymphoma | Acute Lymphoblastic Leukemia | Anaplastic Astrocytoma
  • Age: Between 0 - 100 Years
  • Gender: Male or Female

Inclusion Criteria

Patients of all ages with AML, ALL, MDS, NHL, HL, AA, or SCD are eligible.

Any planned conditioning regimen and GVHD prophylaxis approach is eligible.

Patients must be considered suitable allogeneic transplant candidates at the time of enrollment based on medical history, physical examination, and available laboratory tests. Specific testing for organ function is not required for eligibility but, if available, these tests should be used by the treating physician to judge transplant suitability.

Patient and physician must intend to proceed with allogeneic HCT within the next 6 months if a suitable donor is identified.

Recruitment Status

Open

Contact the research team to learn more about this study.

Fields marked with asterisk (*) are required

Please verify that you are not a bot.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Volunteer Sign up

Volunteer Registry

Create your profile and be matched to research opportunities

Register Now!

Contact Us

If you need help finding a study or have any questions, please contact us at inhealth@iu.edu or by phone at (888) 264-0005.